Información:
Error:
ID
33559
Descripción
An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01266564
Link
https://clinicaltrials.gov/show/NCT01266564
Palabras clave
Versiones (1)
- 13/12/18 13/12/18 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
13 de diciembre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Colorectal Cancer NCT01266564
Eligibility Colorectal Cancer NCT01266564
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT01266564
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Adult | Age
Item
adult patients, age >/=18 years
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Secondary malignant neoplasm of large intestine
Item
proven metastatic colorectal carcinoma
boolean
C0346973 (UMLS CUI [1])
Measurable Disease
Item
patients have measurable disease
boolean
C1513041 (UMLS CUI [1])
First line treatment | Avastin
Item
patients are eligible to receive first-line avastin
boolean
C1708063 (UMLS CUI [1])
C1135130 (UMLS CUI [2])
C1135130 (UMLS CUI [2])
Patient data Release Consent
Item
patients have signed data release form
boolean
C2707520 (UMLS CUI [1,1])
C1283071 (UMLS CUI [1,2])
C1511481 (UMLS CUI [1,3])
C1283071 (UMLS CUI [1,2])
C1511481 (UMLS CUI [1,3])
Medical contraindication Avastin
Item
contra-indication to receive avastin according to the local labeling
boolean
C1301624 (UMLS CUI [1,1])
C1135130 (UMLS CUI [1,2])
C1135130 (UMLS CUI [1,2])
Study Subject Participation Status
Item
participation in a clinical study within 30 days prior to enrolment
boolean
C2348568 (UMLS CUI [1])
Primary malignant neoplasm Other
Item
patients have any other primary cancer
boolean
C1306459 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
Biological agents
Item
concomitant treatment with other biologics
boolean
C0005515 (UMLS CUI [1])
Cancer Other | Exception Basal cell carcinoma
Item
history of other malignant disease in the past 5 years except basal cell carcinoma
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])